
    
      1. Evogliptin 5mg Group: Administration with Evogliptin 5mg for 0-52 weeks.

        2. Placebo Group: Administration with Placebo for 0-24 weeks, and with Evogliptin 5mg for
           24-52 weeks.
    
  